Nasdaq: AUPH
Aurinia Pharmaceuticals insiders
The officers, directors and 10% owners of Aurinia Pharmaceuticals Inc. who hold the most stock, valued at the live AUPH price.
$14.89
AUPH today −$240K (−1.59%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their AUPH stock
- $62.7M
- Market value
- $2.00B
- Held by ranked insiders
- 3.14%
Insiders by value of AUPH holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Peter Greenleaf | Chief Executive Officer | 1,840,379 | $27.4M | 1.37% | 4044th |
| 2 | Matthew Maxwell Donley | Chief Operating Officer | 680,299 | $10.1M | 0.51% | 8695th |
| 3 | Stephen P. Robertson | Chief Legal Officer | 576,981 | $8.6M | 0.43% | 9835th |
| 4 | Joseph M. Miller | Chief Financial Officer | 576,421 | $8.6M | 0.43% | 9843rd |
| 5 | Scott Habig | Chief Commercial Officer | 456,338 | $6.8M | 0.34% | 11648th |
| 6 | George M. Milne Jr. | Director | 78,733 | $1.2M | <0.1% | 4876th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Aurinia Pharmaceuticals; see each profile for the filing.